Pharmaceutical

Bruker to buy cell biology company PhenomeX for $108m

Bruker has entered into a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m.

Aug 18, 2023 - 20:00
Bruker to buy cell biology company PhenomeX for $108m
Bruker has entered into a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m.
Read the original article

Tags:

Previous Article

Coeptis licenses Deverra Therapeutics’ clinical stage assets

Next Article

How competitive intelligence can give pharma companies an edge

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Many employer health plans won’t pay for obesity drugs; FDA panel rejects Intercept NASH drug

STAT+: Pharmalittle: Many employer health plans won’t p...

May 23, 2023

STAT+: Delfi launches its blood test to screen for lung cancer – and reveals challenges for liquid biopsies

STAT+: Delfi launches its blood test to screen for lung...

Oct 10, 2023

UK MHRA grants marketing authorisation for argenx’s gMG therapy

UK MHRA grants marketing authorisation for argenx’s gMG...

Mar 19, 2023